GSK Commits to UK Manufacturing with £275m Investments Across Three Sites


Stephan Rau and Emmanuelle Trombe were cited for their analysis that while “uncertainty created by the Brexit vote is generally bad for the economy,” there could be some upsides, and “UK pharmaceutical companies like GSK may even benefit from a lower pound, which will enable higher profitability.”